Analgesic Effect of Levobupivacaine in Breast Augmentation

• Status: Suspended
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine whether levobupivacaine is effective in the acute postoperative pain treatment in periprosthetic breast augmentation

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: General University Hospital of Valencia; Valencia University General Hospital
• Treatments: Analgesics; Bupivacaine; Levobupivacaine

Criteria

Inclusion Criteria:

• Women> 18 and <= 65 years

• Mammoplasty Surgery with cohesive silicone gel prosthesis in subpectoral plane

• ASA I and II

• Informed consent signed

Exclusion Criteria:

• Rejection of the patient

• ASA III or higher

• Other conditions that warrant their inclusion as medically indicated (eg psychiatric illness).

• Allergy to NSAIDs, local anesthetics and / or morphine

• Patients treated for chronic pain

• Placement of drains for surgical needs